ACM
VNDA icon

AIGH Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

AIGH Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Sell
2,044,169
-705,831
-26% -$4.61M 0.79% 23
2026
Q1 		$19M Buy
2,750,000
+751,569
+38% +$5.8M 2.59% 9
2025
Q4 		$17.6M Buy
+1,998,431
New +$11M 4.27% 7
2021
Q1 		– Sell
-349,463
Closed -$4.59M – 62
2020
Q4 		$4.59M Buy
+349,463
New +$4.21M 1.87% 17

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

AIGH Capital Management's VNDA Position: Q2 2026 in Review

AIGH Capital Management reduced its Vanda Pharmaceuticals (VNDA) stake by 26% in Q2 2026, selling an estimated $4.61M and leaving 2,044,169 shares worth $12.5M. The position accounts for 0.79% of the portfolio, ranked #23.

AIGH Capital Management first reported a position in VNDA in Q4 2020 and has held it in 4 quarters since. The position peaked at $19M in Q1 2026. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • AIGH Capital Management held 2,044,169 shares of Vanda Pharmaceuticals worth $12.5M as of Q2 2026.
  • AIGH Capital Management sold 705,831 Vanda Pharmaceuticals shares in Q2 2026, an estimated $4.61M.
  • Vanda Pharmaceuticals made up 0.79% of AIGH Capital Management's portfolio in Q2 2026, its #23 holding.
  • AIGH Capital Management first reported a position in Vanda Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • AIGH Capital Management's Vanda Pharmaceuticals position peaked at $19M in Q1 2026.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.